Chronic kidney disease (CKD) is a complex condition with a prevalence of 10–15%
worldwide. An inverse-graded relationship exists between cardiovascular events and …

Cardiovascular diseases such as coronary artery disease, congestive heart failure,
arrhythmias and sudden cardiac death represent main causes of morbidity and mortality in …

Cardiovascular diseases represent the main causes of morbidity and mortality in patients
with chronic kidney disease (CKD). According to a well-established classification …

Chronic kidney disease (CKD) and ESRD, treated with conventional hemo-or peritoneal
dialysis are both associated with a high prevalence of an increase in left ventricular mass …

Objectives: Athlete's heart represents a structural and functional adaptation to regular
endurance exercise. Background: While left ventricular (LV) hypertrophy of the athlete's …

Left ventricular (LV) hypertrophy (LVH) is a risk factor for mortality in patients with end-stage
renal disease (ESRD). Whether the attenuation of LVH has a positive effect on survival of …

Physiologically, left ventricular hypertrophy is primarily an adaptive remodeling process,
compensating for an increase in workload placed on the heart with the aim of minimizing …

Allopurinol ameliorates endothelial dysfunction and arterial stiffness among patients without
chronic kidney disease (CKD), but it is unknown if it has similar effects among patients with …

Left ventricular hypertrophy (LVH) is exceedingly frequent in patients undergoing dialysis.
Cardiac mass is proportional to body size, but the influence of various indexing methods has …

Background Intradialytic cycling (IDC), delivered during haemodialysis (HD), has the
potential to improve many health issues. This systematic review and meta-analysis examine …